The Center of Aquaculture Technologies Partners with UMBC to Advance Sterility Solutions in Aquaculture

    The Center of Aquaculture Technologies (CAT), a global leader in sustainable genetic innovation for aquaculture, today announced the signing of an exclusive licensing agreement with the University of Maryland, Baltimore County (UMBC) covering two patents related to the induction of sterility in finfish using Morpholinos. This strategic collaboration strengthens CAT’s intellectual property portfolio…

Read More

A pivotal moment for genome editing in aquaculture

CAT’s CEO, John Buchanan, and genome editing field lead Matt Josephson recently joined Ramon Amaral, CEO of Brazilian Fish, in a conversation with The Fish Site to share more of the story behind our new strategic partnership. As previously announced, CAT is working with Brazilian Fish to integrate CAT’s genome editing technology into their breeding…

Read More

Why aquaculture is fertile ground for sterile stocks

Sterility in aquaculture is more than just a breeding technique  — it’s a powerful tool for advancing sustainability, animal welfare, and industry efficiency. Debbie Plouffe and Xavier Lauth recently shared with Rob Fletcher Senior editor at The Fish Site why genome editing stands out as the most efficient and effective solution for inducing sterility in…

Read More

Overcoming the ‘sterility paradox’

CAT genome editing sterility technology

By using gene editing advancements, researchers at the Center for Aquaculture Technologies (CAT), figured out how to keep farmed fish from wasting energy on reproduction while still producing offspring.

Read More